Home » Topics » BioWorld Asia

BioWorld Asia
RSS

NiCox, Bausch & Lomb Ink $179.5M Deal in Glaucoma

March 10, 2010

By Cormac Sheridan

SpePharm Gets Product Rights, Sales Team from TopoTarget

March 10, 2010

By Cormac Sheridan

New Ion Channel Possible Target for Atrial Fibrillation

March 10, 2010

By Sharon Kingman

$200M CellCentric-Takeda Deal Could Boost Epigenetics Arena

March 3, 2010

Moving Molecules Could Lead to New Heart Failure Therapies

March 3, 2010

By Sharon Kingman

Actelion Shares Fall on Tracleer Miss; IPF Bid for Drug Dropped

March 3, 2010

By Cormac Sheridan

Renovo, Shire Revise Pact for Scarring Product Juvista

March 3, 2010

Myotec Raises £5.6M to Fund Cachexia, Sarcopenia Studies

March 3, 2010

Move Over, Cerezyme; Shire's Vpriv Gets Official FDA Nod

March 3, 2010

Other News To Note

March 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...